Phase II trial of 4'-epi-doxorubicin in metastatic melanoma

Cancer Treat Rep. 1984 Dec;68(12):1509-10.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antibiotics, Antineoplastic / toxicity*
  • Doxorubicin / therapeutic use
  • Doxorubicin / toxicity*
  • Drug Evaluation
  • Epirubicin
  • Female
  • Humans
  • Male
  • Melanoma / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Stereoisomerism

Substances

  • Antibiotics, Antineoplastic
  • Epirubicin
  • Doxorubicin